MeCP2: Structure and function

Biochemistry and Cell Biology

Volumn 89, Issue 1, 2011, Pages 1-11

  Adkins, Nicholas L ^a,b   Georgel, Philippe T ^a  

^a MARSHALL UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

chromatin; histone tail; MeCP2; methylated DNA binding protein; Rett syndrome

Indexed keywords

CHROMATIN; HISTONE TAIL; MECP2; METHYLATED DNA BINDING PROTEIN; RETT SYNDROME;

CHEMICAL ACTIVATION; CHROMOSOMES; DNA; GENE EXPRESSION REGULATION; NUCLEIC ACIDS; TRANSCRIPTION;

PROTEINS;

METHYL CPG BINDING PROTEIN 2; DNA BINDING PROTEIN; ISOPROTEIN; MBD1 PROTEIN, HUMAN; NONHISTONE PROTEIN; TRANSCRIPTION FACTOR;

CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE MUTATION; HUMAN; IN VITRO STUDY; NONHUMAN; NUCLEOSOME; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; RETT SYNDROME; REVIEW; ANIMAL; CHEMISTRY; GENETICS; MOUSE; MUTATION; PHYSIOLOGY;

ANIMALS; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MICE; MUTATION; NUCLEOSOMES; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RETT SYNDROME; TRANSCRIPTION FACTORS;

EID: 79955015395     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/O10-112     Document Type: Review

References (91)

1. Adams, V.H., McBryant, S.J., Wade, P.A., Woodcock, C.L., and Hansen, J.C. 2007. Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2. J. Biol. Chem. 282(20): 15057-15064. doi:10.1074/jbc.M700855200. PMID:17371874. (Pubitemid 47093337)
2. Allain, F.H., Gubser, C.C., Howe, P.W., Nagai, K., Neuhaus, D., and Varani, G. 1996. Specificity of ribonucleoprotein interaction determined by RNA folding during complex formulation. Nature, 380(6575): 646-650. doi:10.1038/380646a0. PMID: 8602269. (Pubitemid 26119021)
3. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U., and Zoghbi, H.Y. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23(2): 185-188. doi:10.1038/13810. PMID: 10508514. (Pubitemid 29455390)
4. Bakker, J., Lin, X., and Nelson, W.G. 2002. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated p-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells. J. Biol. Chem. 277(25): 22573-22580. doi:10.1074/jbc.M203009200. PMID:11960994. (Pubitemid 34967234)
5. Ballestar, E., Yusufzai, T.M., and Wolffe, A.P. 2000. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry, 39(24): 7100-7106. doi:10.1021/bi0001271. PMID:10852707. (Pubitemid 30413098)
6. Ballestar, E., Paz, M.F., Valle, L., Wei, S., Fraga, M.F., Espada, J., et al. 2003. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J. 22(23): 6335-6345. doi:10.1093/emboj/ cdg604. PMID:14633992. (Pubitemid 37522590)
7. Bell, A.C., and Felsenfeld, G. 2000. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature, 405(6785): 482-485. doi:10.1038/35013100. PMID:10839546. (Pubitemid 30367427)
8. Benson, E.E., and Linderstrøm-Lang, K. 1959. Deuterium exchange between myoglobin and water. Biochim. Biophys. Acta, 32: 579-581. PMID:13798998.
9. Bernard, D., Gil, J., Dumont, P., Rizzo, S., Monté, D., Quatannens, B., et al. 2006. The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth. Oncogene, 25(9): 1358- 1366. doi:10.1038/sj.onc.1209179. PMID:16331274. (Pubitemid 43336464)
10. Bothner, B., Lewis, W.S., DiGiammarino, E.L., Weber, J.D., Bothner, S.J., and Kriwacki, R.W. 2001. Defining the molecular basis of Arf and Hdm2 interactions. J. Mol. Biol. 314(2): 263-277. doi:10.1006/jmbi.2001.5110. PMID:11718560. (Pubitemid 33105092)
11. Bourhis, J.M., Johansson, K., Receveur-Bréchot, V., Oldfield, C.J., Dunker, K.A., Canard, B., and Longhi, S. 2004. The C-terminal domain of measles virus nucleoprotein belongs to the class of intrinsically disordered proteins that fold upon binding to their physiological partner. Virus Res. 99(2): 157-167. doi:10.1016/j. virusres.2003.11.007. PMID:14749181. (Pubitemid 38121665)
12. Buschdorf, J.P., and Strätling, W.H. 2004. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome. J. Mol. Med. 82(2): 135-143. doi:10.1007/s00109- 003-0497-9. PMID:14618241. (Pubitemid 38299712)
13. Carney, R.M., Wolpert, C.M., Ravan, S.A., Shahbazian, M., Ashley- Koch, A., Cuccaro, M.L., et al. 2003. Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr. Neurol. 28(3): 205-211. PMID:12770674. (Pubitemid 36593431)
14. Cary, P.D., Moss, T., and Bradbury, E.M. 1978. High-resolution proton-magnetic-resonance studies of chromatin core particles. Eur. J. Biochem. 89(2): 475-482. doi:10.1111/j.1432-1033. 1978.tb12551.x. PMID:710406. (Pubitemid 8405810)
15. Chahrour, M., Jung, S.Y., Shaw, C., Zhou, X., Wong, S.T., Qin, J., and Zoghbi, H.Y. 2008. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science, 320(5880): 1224-1229. doi:10.1126/science. 1153252. PMID: 18511691. (Pubitemid 351929512)
16. Couvert, P., Bienvenu, T., Aquaviva, C., Poirier, K., Moraine, C., Gendrot, C., et al. 2001. MECP2 is highly mutated in X-linked mental retardation. Hum. Mol. Genet. 10(9): 941-946. doi:10. 1093/hmg/10.9.941. PMID:11309367. (Pubitemid 32401410)
17. Denslow, S.A., and Wade, P.A. 2007. The human Mi-2/NuRD complex and gene regulation. Oncogene, 26(37): 5433-5438. doi:10.1038/sj.onc.1210611. PMID:17694084. (Pubitemid 47255925)
18. DiGiammarino, E.L., Filippov, I., Weber, J.D., Bothner, B., and Kriwacki, R.W. 2001. Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein. Biochemistry, 40(8): 2379-2386. doi:10.1021/bi0024005. PMID:11327858. (Pubitemid 32171710)
19. Dragich, J.M., Kim, Y.H., Arnold, A.P., and Schanen, N.C. 2007. Differential distribution of the MeCP2 splice variants in the postnatal mouse brain. J. Comp. Neurol. 501(4): 526-542. doi:10.1002/cne.21264. PMID:17278130. (Pubitemid 46622494)
20. Dreyer, T., Valler, M.J., Kay, J., Charlton, P., and Dunn, B.M. 1985. The selectivity of action of the aspartic-proteinase inhibitor IA3 from yeast (Saccharomyces cerevisiae). Biochem. J. 231(3): 777-779. PMID:3907626. (Pubitemid 16194578)
21. Feng, Q., and Zhang, Y. 2003. The NuRD complex: linking histone modification to nucleosome remodeling. Curr. Top. Microbiol. Immunol. 274: 269-290. PMID:12596911. (Pubitemid 36118995)
22. Fuks, F., Hurd, P.J., Wolf, D., Nan, X., Bird, A.P., and Kouzarides, T. 2003. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278(6): 4035-4040. doi:10.1074/jbc.M210256200. PMID:12427740. (Pubitemid 36801137)
23. Georgel, P.T., Horowitz-Scherer, R.A., Adkins, N., Woodcock, C.L., Wade, P.A., and Hansen, J.C. 2003. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem. 278(34): 32181-32188. doi:10.1074/jbc.M305308200. PMID: 12788925. (Pubitemid 37048409)
24. Gonzalez-Zulueta, M., Bender, C.M., Yang, A.S., Nguyen, T., Beart, R.W., Van Tornout, J.M., and Jones, P.A. 1995. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55(20): 4531-4535. PMID:7553622.
25. Green, T.B., Ganesh, O., Perry, K., Smith, L., Phylip, L.H., Logan, T.M., et al. 2004. IA3, an aspartic proteinase inhibitor from Saccharomyces cerevisiae, is intrinsically unstructured in solution. Biochemistry, 43(14): 4071-4081. doi:10.1021/bi034823n. PMID:15065849. (Pubitemid 38445626)
26. Hagberg, B. 1985. Rett's syndrome: prevalence and impact on progressive severe mental retardation in girls. Acta Paediatr. Scand. 74(3): 405-408. doi:10.1111/j.1651-2227.1985.tb10993.x. PMID:4003065. (Pubitemid 15034481)
27. Hagberg, B., Aicardi, J., Dias, K., and Ramos, O. 1983. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann. Neurol. 14(4): 471-479. doi:10.1002/ana.410140412. PMID: 6638958. (Pubitemid 13010048)
28. Hammer, S., Dorrani, N., Dragich, J., Kudo, S., and Schanen, C. 2002. The phenotypic consequences of MECP2 mutations extend beyond Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 8(2): 94-98. doi:10.1002/mrdd.10023. PMID:12112734. (Pubitemid 34606520)
29. Hark, A.T., Schoenherr, C.J., Katz, D.J., Ingram, R.S., Levorse, J.M., and Tilghman, S.M. 2000. CTCF mediates methylationsensitive enhancer-blocking activity at the H19/Igf2 locus. Nature, 405(6785): 486-489. doi:10.1038/ 35013106. PMID: 10839547. (Pubitemid 30367428)
30. Hendrich, B., and Bird, A. 1998. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18(11): 6538-6547. PMID:9774669. (Pubitemid 28500543)
31. Hendrich, B., and Tweedie, S. 2003. The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet. 19(5): 269-277. doi:10.1016/S0168-9525(03) 00080-5. PMID:12711219. (Pubitemid 36507009)
32. Hendrich, B., Abbott, C., McQueen, H., Chambers, D., Cross, S., and Bird, A. 1999. Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes. Mamm. Genome, 10(9): 906-912. doi:10.1007/ s003359901112. PMID:10441743. (Pubitemid 29445381)
33. Hendrich, B., Guy, J., Ramsahoye, B., Wilson, V.A., and Bird, A. 2001. Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev. 15(6): 710-723. doi:10.1101/gad.194101. PMID:11274056. (Pubitemid 32244900)
34. Hite, K.C., Adams, V.H., and Hansen, J.C. 2009. Recent advances in MeCP2 structure and function. Biochem. Cell Biol. 87(1): 219-227. doi:10.1139/O08-115. PMID:19234536.
35. Holmgren, C., Kanduri, C., Dell, G., Ward, A., Mukhopadhya, R., Kanduri, M., et al. 2001. CpG methylation regulates the Igf2/ H19 insulator. Curr. Biol. 11(14): 1128-1130. doi:10.1016/ S0960-9822(01)00314-1. PMID:11509237. (Pubitemid 32675766)
36. Horike, S., Cai, S., Miyano, M., Cheng, J.F., and Kohwi- Shigematsu, T. 2005. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet. 37(1): 31-40. PMID:15608638. (Pubitemid 40070937)
37. Jones, P.A., Gonzalgo, M.L., Tsutsumi, M., and Bender, C.M. 1998. DNA methylation in bladder cancer. Eur. Urol. 33(Suppl. 4): 7-8. doi:10.1159/000052251. PMID:9615197. (Pubitemid 28230274)
38. Kaji, K., Caballero, I.M., MacLeod, R., Nichols, J., Wilson, V.A., and Hendrich, B. 2006. The NuRD component Mbd3 is required for pluripotency of embryonic stem cells. Nat. Cell Biol. 8(3): 285-292. doi:10.1038/ncb1372. PMID:16462733. (Pubitemid 43336071)
39. Klose, R.J., and Bird, A.P. 2006. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31(2): 89-97. doi:10.1016/j.tibs.2005.12. 008. PMID:16403636. (Pubitemid 43221841)
40. Kondo, E., Gu, Z., Horii, A., and Fukushige, S. 2005. The thymine DNA glycosylase MBD4 represses transcription and is associated with methylated p16INK4a and hMLH1 genes. Mol. Cell. Biol. 25(11): 4388-4396. doi:10.1128/MCB.25.11.4388-4396. 2005. PMID:15899845. (Pubitemid 40705746)
41. Kriaucionis, S., and Bird, A. 2004. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res. 32(5): 1818-1823. doi:10.1093/nar/gkh349. PMID: 15034150. (Pubitemid 38832727)
42. Kumar, A., Kamboj, S., Malone, B.M., Kudo, S., Twiss, J.L., Czymmek, K.J., et al. 2008. Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. J. Cell Sci. 121(Pt 7): 1128-1137. doi:10.1242/ jcs.016865. PMID:18334558. (Pubitemid 351639431)
43. Lewis, J.D., Meehan, R.R., Henzel, W.J., Maurer-Fogy, I., Jeppesen, P., Klein, F., and Bird, A. 1992. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69(6): 905-914. doi:10.1016/ 0092-8674(92)90610-O. PMID:1606614.
44. Li, M., Phylip, L.H., Lees, W.E., Winther, J.R., Dunn, B.M., Wlodawer, A., et al. 2000. The aspartic proteinase from Saccharomyces cerevisiae folds its own inhibitor into a helix. Nat. Struct. Biol. 7(2): 113-117. doi:10.1038/72378. PMID: 10655612. (Pubitemid 30082507)
45. Liu, X.I., Korde, N., Jakob, U., and Leichert, L.I. 2006. CoSMoS: Conserved Sequence Motif Search in the proteome. BMC Bioinformatics, 7(1): 37. doi:10.1186/1471-2105-7-37. PMID: 16433915.
46. Magdinier, F., and Wolffe, A.P. 2001. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc. Natl. Acad. Sci. U.S.A. 98(9): 4990-4995. doi:10.1073/pnas. 101617298. PMID:11309512. (Pubitemid 32397070)
47. Markus, M.A., Hinck, A.P., Huang, S., Draper, D.E., and Torchia, D.A. 1997. High resolution solution structure of ribosomal protein L11-C76, a helical protein with a flexible loop that becomes structured upon binding to RNA. Nat. Struct. Biol. 4(1): 70-77. doi:10.1038/nsb0197-70. PMID:8989327. (Pubitemid 27020928)
48. Meehan, R.R., Lewis, J.D., McKay, S., Kleiner, E.L., and Bird, A.P. 1989. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell, 58(3): 499-507. doi:10.1016/0092-8674(89)90430-3. PMID:2758464.
49. Meehan, R.R., Lewis, J.D., and Bird, A.P. 1992. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 20(19): 5085-5092. doi:10.1093/nar/20.19.5085. PMID:1408825.
50. Meloni, I., Bruttini, M., Longo, I., Mari, F., Rizzolio, F., D'Adamo, P., et al. 2000. A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am. J. Hum. Genet. 67(4): 982-985. doi:10.1086/ 303078. PMID:10986043.
51. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., et al. 1995. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/ CDKN2/MTS1 in human cancers. Nat. Med. 1(7): 686-692. doi:10.1038/nm0795-686. PMID:7585152.
52. Millar, D.S., Warnecke, P.M., Melki, J.R., and Clark, S.J. 2002. Methylation sequencing from limiting DNA: embryonic, fixed, and microdissected cells. Methods, 27(2): 108-113. doi:10. 1016/S1046-2023(02)00061-0. PMID:12095267. (Pubitemid 34757120)
53. Miltenberger-Miltenyi, G., and Laccone, F. 2003. Mutations and polymorphisms in the human methyl CpG-binding protein MECP2. Hum. Mutat. 22(2): 107-115. doi:10.1002/humu. 10243. PMID:12872250. (Pubitemid 36950807)
54. Mnatzakanian, G.N., Lohi, H., Munteanu, I., Alfred, S.E., Yamada, T., MacLeod, P.J., et al. 2004. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat. Genet. 36(4): 339-341. doi:10.1038/ ng1327. PMID:15034579. (Pubitemid 38437255)
55. Muro-Pastor, M.I., Barrera, F.N., Reyes, J.C., Florencio, F.J., and Neira, J.L. 2003. The inactivating factor of glutamine synthetase, IF7, is a ''natively unfolded'' protein. Protein Sci. 12(7): 1443-1454. doi:10.1110/ps.0303203. PMID:12824490. (Pubitemid 36759348)
56. Nan, X., Campoy, F.J., and Bird, A. 1997. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88(4): 471-481. doi:10.1016/S0092-8674(00)81887-5. PMID:9038338. (Pubitemid 27154412)
57. Nan, X., Ng, H.H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, R.N., and Bird, A. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393(6683): 386-389. doi:10.1038/ 30764. PMID:9620804. (Pubitemid 28269714)
58. Nanduri, S., Carpick, B.W., Yang, Y., Williams, B.R., and Qin, J. 1998. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J. 17(18): 5458-5465. doi:10.1093/emboj/17.18.5458. PMID:9736623. (Pubitemid 28427059)
59. Ng, H.H., and Bird, A. 1999. DNA methylation and chromatin modification. Curr. Opin. Genet. Dev. 9(2): 158-163. doi:10. 1016/S0959-437X(99)80024-0. PMID:10322130. (Pubitemid 29158549)
60. Oldfield, C.J., Ulrich, E.L., Cheng, Y., Dunker, A.K., and Markley, J.L. 2005. Addressing the intrinsic disorder bottleneck in structural proteomics. Proteins, 59(3): 444-453. doi:10.1002/prot. 20446. PMID:15789434. (Pubitemid 40594289)
61. Orrico, A., Lam, C., Galli, L., Dotti, M.T., Hayek, G., Tong, S.F., et al. 2000. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett. 481(3): 285-288. doi:10.1016/S0014-5793(00)01994-3. PMID:11007980.
62. Paull, T.T., Cortez, D., Bowers, B., Elledge, S.J., and Gellert, M. 2001. Direct DNA binding by Brca1. Proc. Natl. Acad. Sci. U.S.A. 98(11): 6086-6091. doi:10.1073/pnas.111125998. PMID: 11353843. (Pubitemid 32488197)
63. Prokhortchouk, A., Hendrich, B., Jørgensen, H., Ruzov, A., Wilm, M., Georgiev, G., et al. 2001. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev. 15(13): 1613-1618. doi:10.1101/gad.198501. PMID: 11445535. (Pubitemid 32702582)
64. Prokhortchouk, A., Sansom, O., Selfridge, J., Caballero, I.M., Salozhin, S., Aithozhina, D., et al. 2006. Kaiso-deficient mice show resistance to intestinal cancer. Mol. Cell. Biol. 26(1): 199-208. doi:10.1128/MCB.26.1.199- 208.2006. PMID:16354691.
65. Pullen, R.A., Jenkins, J.A., Tickle, I.J., Wood, S.P., and Blundell, T.L. 1975. The relation of polypeptide hormone structure and flexibility to receptor binding: the relevance of X-ray studies on insulins, glucagon and human placental lactogen. Mol. Cell. Biochem. 8(1): 5-20. doi:10.1007/BF01731645. PMID:170505.
66. Romero, P., Obradovic, Z., Li, X., Garner, E.C., Brown, C.J., and Dunker, A.K. 2001. Sequence complexity of disordered protein. Proteins, 42(1): 38-48. doi:10.1002/1097-0134(20010101) 42:1<38::AID-PROT50>3.0.CO;2-3. PMID:11093259.
67. Ruzov, A., Dunican, D.S., Prokhortchouk, A., Pennings, S., Stancheva, I., Prokhortchouk, E., and Meehan, R.R. 2004. Kaiso is a genome-wide repressor of transcription that is essential for amphibian development. Development, 131(24): 6185-6194. doi:10.1242/dev.01549. PMID:15548582. (Pubitemid 40123931)
68. Sansom, O.J., Maddison, K., and Clarke, A.R. 2007. Mechanisms of disease: methyl-binding domain proteins as potential therapeutic targets in cancer. Nat. Clin. Pract. Oncol. 4(5): 305-315. doi:10.1038/ncponc0812. PMID:17464338. (Pubitemid 46758788)
69. Sarraf, S.A., and Stancheva, I. 2004. Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol. Cell, 15(4): 595-605. doi:10.1016/j.molcel.2004.06.043. PMID:15327775. (Pubitemid 39141786)
70. Scully, R., Chen, J., Ochs, R.L., Keegan, K., Hoekstra, M., Feunteun, J., and Livingston, D.M. 1997. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell, 90(3): 425-435. doi:10.1016/ S0092-8674(00)80503-6. PMID:9267023. (Pubitemid 27347233)
71. Shibayama, A., Cook, E.H., Jr., Feng, J., Glanzmann, C., Yan, J., Craddock, N., et al. 2004. MECP2 structural and 3'-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 128B(1): 50-53. doi:10.1002/ajmg.b.30016. PMID:15211631. (Pubitemid 38849918)
72. Spolar, R.S., and Record, M.T., Jr. 1994. Coupling of local folding to site-specific binding of proteins to DNA. Science, 263(5148): 777-784. doi:10.1126/science.8303294. PMID:8303294. (Pubitemid 24093205)
73. Szabó, P.E., Pfeifer, G.P., Miao, F., O'Connor, T.R., and Mann, J.R. 2000. Improved in vivo dimethyl sulfate footprinting using AlkA protein: DNA-protein interactions at the mouse H19 gene promoter in primary embryo fibroblasts. Anal. Biochem. 283(1): 112-116. doi:10.1006/abio.2000.4631. PMID:10929817. (Pubitemid 30469759)
74. Tao, J., Hu, K., Chang, Q., Wu, H., Sherman, N.E., Martinowich, K., et al. 2009. Phosphorylation of MeCP2 at serine 80 regulates its chromatin association and neurological function. Proc. Natl. Acad. Sci. U.S.A. 106(12): 4882-4887. doi:10.1073/pnas. 0811648106. PMID:19225110.
75. Uversky, V.N., Oldfield, C.J., and Dunker, A.K. 2005. Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J. Mol. Recognit. 18(5): 343-384. doi:10. 1002/jmr.747. PMID:16094605. (Pubitemid 41341287)
76. Van Esch, H., Bauters, M., Ignatius, J., Jansen, M., Raynaud, M., Hollanders, K., et al. 2005. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet. 77(3): 442-453. doi:10.1086/444549. PMID:16080119. (Pubitemid 41192650)
77. Wade, P.A., Gegonne, A., Jones, P.L., Ballestar, E., Aubry, F., and Wolffe, A.P. 1999. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat. Genet. 23(1): 62-66. doi:10.1038/12664. PMID:10471500. (Pubitemid 29418789)
78. Wakefield, R.I., Smith, B.O., Nan, X., Free, A., Soteriou, A., Uhrin, D., et al. 1999. The solution structure of the domain from MeCP2 that binds to methylated DNA. J. Mol. Biol. 291(5): 1055-1065. doi:10.1006/jmbi.1999.3023. PMID:10518942. (Pubitemid 29423769)
79. Watson, P., Black, G., Ramsden, S., Barrow, M., Super, M., Kerr, B., and Clayton-Smith, J. 2001. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J. Med. Genet. 38(4): 224-228. doi:10. 1136/jmg.38.4.224. PMID:11283202. (Pubitemid 32324502)
80. Weiss, M.A., Ellenberger, T., Wobbe, C.R., Lee, J.P., Harrison, S.C., and Struhl, K. 1990. Folding transition in the DNA-binding domain of GCN4 on specific binding to DNA. Nature, 347(6293): 575-578. doi:10.1038/347575a0. PMID:2145515.
81. Wischnewski, F., Friese, O., Pantel, K., and Schwarzenbach, H. 2007. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGEA3, and MAGE-A12 gene promoters. Mol. Cancer Res. 5(7): 749-759. doi:10.1158/1541-7786.MCR-06-0364. PMID: 17634428. (Pubitemid 47105493)
82. Wong, T.T., Sethi, C., Daniels, J.T., Limb, G.A., Murphy, G., and Khaw, P.T. 2002. Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv. Ophthalmol. 47(3): 239-256. doi:10.1016/S0039-6257(02) 00287-4. PMID: 12052410. (Pubitemid 34575357)
83. Yasui, D.H., Peddada, S., Bieda, M.C., Vallero, R.O., Hogart, A., Nagarajan, R.P., et al. 2007. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl. Acad. Sci. U.S.A. 104(49): 19416-19421. doi:10.1073/pnas.0707442104. PMID:18042715.
84. Yoon, H.G., Chan, D.W., Reynolds, A.B., Qin, J., and Wong, J. 2003. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol. Cell, 12(3): 723-734. doi:10.1016/j.molcel.2003.08.008. PMID:14527417. (Pubitemid 37222492)
85. Young, J.I., Hong, E.P., Castle, J.C., Crespo-Barreto, J., Bowman, A.B., Rose, M.F., et al. 2005. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl. Acad. Sci. U.S.A. 102(49): 17551-17558. doi:10.1073/pnas.0507856102. PMID:16251272.
86. Zhang, H., Somasundaram, K., Peng, Y., Tian, H., Zhang, H., Bi, D., et al. 1998. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene, 16(13): 1713-1721. doi:10.1038/sj.onc. 1201932. PMID:9582019.
87. Zhang, Y., Ng, H.H., Erdjument-Bromage, H., Tempst, P., Bird, A., and Reinberg, D. 1999. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13(15): 1924-1935. doi:10.1101/gad. 13.15.1924. PMID:10444591. (Pubitemid 29407360)
88. Zhao, X., Ueba, T., Christie, B.R., Barkho, B., McConnell, M.J., Nakashima, K., et al. 2003. Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc. Natl. Acad. Sci. U.S.A. 100(11): 6777-6782. doi:10.1073/pnas.1131928100. PMID:12748381. (Pubitemid 36666656)
89. Zhong, Q., Chen, C.F., Li, S., Chen, Y., Wang, C.C., Xiao, J., et al. 1999. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science, 285(5428): 747-750. doi:10.1126/science.285.5428.747. PMID:10426999.
90. Zhou, Z., Hong, E.J., Cohen, S., Zhao, W.N., Ho, H.Y., Schmidt, L., et al. 2006. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron, 52(2): 255-269. doi:10.1016/j. neuron.2006.09.037. PMID:17046689. (Pubitemid 44548348)
91. Zlatanova, J. 2005. MeCP2: the chromatin connection and beyond. Biochem. Cell Biol. 83(3): 251-262. doi:10.1139/o05-048. PMID:15959553. (Pubitemid 41297195)